These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37988654)

  • 1. Liposomes Containing Zinc-Based Chemotherapeutic Drug Block Proliferation and Trigger Apoptosis in Breast Cancer Cells.
    Siva M; Das K; Guha S; Sivagnanam S; Das G; Saha A; Stewart A; Maity B; Das P
    ACS Appl Bio Mater; 2023 Dec; 6(12):5310-5323. PubMed ID: 37988654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced selectivity towards melanoma cells with zinc(II)-Schiff bases containing imidazole derivatives.
    Côrte-Real L; Sergi B; Yildirim B; Colucas R; Starosta R; Fontrodona X; Romero I; André V; Acilan C; Correia I
    Dalton Trans; 2024 Jun; 53(22):9416-9432. PubMed ID: 38758025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis.
    Icsel C; Yilmaz VT; Aydinlik S; Aygun M
    Dalton Trans; 2020 Jun; 49(23):7842-7851. PubMed ID: 32463408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.
    Bai J; Wang RH; Qiao Y; Wang A; Fang CJ
    Drug Des Devel Ther; 2017; 11():2227-2237. PubMed ID: 28814831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.
    Alexander C; Prajith NU; Priyanka PV; Nithyakumar A; Arockia Samy N
    J Biol Inorg Chem; 2019 May; 24(3):405-418. PubMed ID: 30945024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
    Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
    Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc(II) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells.
    Liu S; Cao W; Yu L; Zheng W; Li L; Fan C; Chen T
    Dalton Trans; 2013 Apr; 42(16):5932-40. PubMed ID: 23463103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
    Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
    Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes Containing Lipid-Soluble Zn(II)-Bis-dipicolylamine Derivatives Show Potential To Be Targeted to Phosphatidylserine on the Surface of Cancer Cells.
    Ayesa U; Gray BD; Pak KY; Chong PL
    Mol Pharm; 2017 Jan; 14(1):147-156. PubMed ID: 28043132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer.
    Tang B; Peng Y; Yue Q; Pu Y; Li R; Zhao Y; Hai L; Guo L; Wu Y
    Eur J Med Chem; 2020 May; 193():112204. PubMed ID: 32172035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polarity-Induced Morphological Transformation with Tunable Optical Output of Terpyridine-Phenanthro[9,10-
    Rana P; Jennifer G A; Rao T S; Mukhopadhyay S; Varathan E; Das P
    ACS Omega; 2023 Dec; 8(51):48855-48872. PubMed ID: 38162736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model.
    Ribeiro N; Albino M; Ferreira A; Escrevente C; Barral DC; Pessoa JC; Reis CP; Gaspar MM; Correia I
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways.
    Bai X; Ali A; Lv Z; Wang N; Zhao X; Hao H; Zhang Y; Rahman FU
    Eur J Med Chem; 2021 Nov; 224():113689. PubMed ID: 34293698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Nitroacridine derivatives arrest cell cycle at G0/G1 phase and induce apoptosis in human breast cancer cells may act as DNA-target anticancer agents.
    Zhou Q; You C; Zheng C; Gu Y; Gu H; Zhang R; Wu H; Sun B
    Life Sci; 2018 Aug; 206():1-9. PubMed ID: 29738780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Zeolite-Y-Encapsulated Zn(II)Salmphen Complex with Targeted Anticancer Property.
    Sakshi S; Dey S; Chowdhury S; Ray S
    ACS Appl Mater Interfaces; 2023 Dec; 15(48):55518-55532. PubMed ID: 38010148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells.
    Wang FY; Tang XM; Wang X; Huang KB; Feng HW; Chen ZF; Liu YN; Liang H
    Eur J Med Chem; 2018 Jul; 155():639-650. PubMed ID: 29935437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organelle-localizable fluorescent chemosensors for site-specific multicolor imaging of nucleoside polyphosphate dynamics in living cells.
    Kurishita Y; Kohira T; Ojida A; Hamachi I
    J Am Chem Soc; 2012 Nov; 134(45):18779-89. PubMed ID: 23098271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
    Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer.
    Bai F; Yin Y; Chen T; Chen J; Ge M; Lu Y; Xie F; Zhang J; Wu K; Liu Y
    Int J Nanomedicine; 2018; 13():1327-1339. PubMed ID: 29563790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
    Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
    J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.